> MEDIA   Overview   Press Releases   Media Stories   Download Center   Video Gallery   Photo Gallery   Media Contacts

Press Releases 2017 2018 2019 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005       October 2007 18 Oct  Biocon's H-1 FY '08 delivers 27% profit  growth 16 Oct  Kiran Mazumdar-Shaw awarded the 'Veuve  Clicquot Initiative For Economic  Development For Asia'     September 2007 21 Sep  Biocon Limited presents human clinical  data on IN-105 (oral insulin) at the EASD  meeting in Amsterdam.   August 2007 09 Aug  Biocon Limited and Abraxis bioscience  announces licensing agreement for the  commercialization of Abraxane in India   Jul 2007 30 Jul  Biocon and Neopharma signed an MOU to  establish Neobiocon 19 Jul  Abraxis Bioscience and Biocon Limited  announce licensing agreement for G-CSF  in North America and the European Union   18 Jul  Biocon to focus on Biopharmaceuticals,  Divesting Enzymes for USD 115 Million to  Novozymes   18 Jul  Revenues at Rs: 272 crores. EBITDA at  Rs: 77 crores. PAT at Rs: 53 crores     June 2007 07 Jun  Biocon signs Memorandum of  Understanding with Deakin University,  Australia   May 2007 31 May  Biocon Limited and Students Working  Against Tobacco (SWAT) conduct unique  campaign on World Anti-Tobacco Day   April 2007 19 Apr  Biocon's FY 2006-07 Performance Shows  Healthy Growth   March 2007 21 Mar  Biocon conducts ground breaking ceremony  of new research facility at Biocon Park 14 Mar  Biocon's Syngene enters into research  partnership with Bristol-Myers Squibb   08 Mar  Biocon Limited Unveils A Comprehensive  Portfolio of Renal Therapy Products     February 2007 20 Feb  Biocon and Bentley Announce Approval and  Expansion of Bentley's Nasulin Phase II  Studies in India   January 2007 18 Jan  Biocon grants exclusive marketing license  for Biomab EGFR for Pakistan 18 Jan  Biocon's 9 months FY 07 delivers robust  profits

Biocon Businesses Recommended sites Biocon on     Home About Us Investor Relations Media Relations Careers Site Map Contact Us Our Growth Accelerators Fact Sheet Branded Formulations Biopharmaceuticals Research Services Active Discovery Program ABLE Karnataka Vision Group on BT Syngene International Biocon Academy                   Report adverse event/side effects and product complaints               * Disclaimer            © 2018, Biocon. All Rights Reserved